Scitech Development, Inc.
Clinical trials sponsored by Scitech Development, Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Vitamin a derivative takes on tough lymphoma Results expected Dec 2026 (estimated)
- New drug ST-001 tested in lung cancer patients who have run out of options Results expected May 2027 (estimated)
-
New drug ST-001 tested in lung cancer patients who have run out of options
Disease control Recruiting nowThis early-phase trial is testing a new drug called ST-001 in people with small cell lung cancer that has returned or not responded to standard treatments. The main goal is to find the safest dose and check for side effects. About 44 participants will receive the drug through an …
Phase 1 • Sponsor: SciTech Development, Inc. • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Vitamin a derivative takes on tough lymphoma
Disease control Recruiting nowThis early-stage trial is testing a new form of fenretinide (a vitamin A-like drug) given by IV for people with T-cell non-Hodgkin lymphoma that has come back or stopped responding to treatment. The study has two parts: first, finding the safest dose in small groups of patients, …
Phase 1 • Sponsor: SciTech Development, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC